Literature DB >> 25819276

Modifications of natural peptides for nanoparticle and drug design.

Andrew P Jallouk1, Rohun U Palekar1, Hua Pan1, Paul H Schlesinger2, Samuel A Wickline3.   

Abstract

Natural products serve as an important source of novel compounds for drug development. Recently, peptides have emerged as a new class of therapeutic agents due to their versatility and specificity for biological targets. Yet, their effective application often requires use of a nanoparticle delivery system. In this chapter, we review the role of natural peptides in the design and creation of nanomedicines, with a particular focus on cell-penetrating peptides, antimicrobial peptides, and peptide toxins. The use of natural peptides in conjunction with nanoparticle delivery systems holds great promise for the development of new therapeutic formulations as well as novel platforms for the delivery of various cargoes.
© 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antimicrobial peptide; Cell-penetrating peptide; Drug delivery; Nanoparticle; Natural peptide; Peptide toxin

Mesh:

Substances:

Year:  2015        PMID: 25819276      PMCID: PMC4750874          DOI: 10.1016/bs.apcsb.2014.12.001

Source DB:  PubMed          Journal:  Adv Protein Chem Struct Biol        ISSN: 1876-1623            Impact factor:   3.507


  156 in total

Review 1.  Therapeutic potential of venom peptides.

Authors:  Richard J Lewis; Maria L Garcia
Journal:  Nat Rev Drug Discov       Date:  2003-10       Impact factor: 84.694

2.  Insight into the mechanism of the peptide-based gene delivery system MPG: implications for delivery of siRNA into mammalian cells.

Authors:  Federica Simeoni; May C Morris; Frederic Heitz; Gilles Divita
Journal:  Nucleic Acids Res       Date:  2003-06-01       Impact factor: 16.971

3.  Making proteins into drugs: assisted delivery of proteins and peptides into living neurons.

Authors:  Gianluca Gallo
Journal:  Methods Cell Biol       Date:  2003       Impact factor: 1.441

4.  PEP-1-PEA-15 protects against toxin-induced neuronal damage in a mouse model of Parkinson's disease.

Authors:  Eun Hee Ahn; Dae Won Kim; Min Jea Shin; Hye Ri Kim; So Mi Kim; Su Jung Woo; Seon Ae Eom; Hyo Sang Jo; Duk-Soo Kim; Sung-Woo Cho; Jinseu Park; Won Sik Eum; Soo Young Choi
Journal:  Biochim Biophys Acta       Date:  2014-01-08

5.  Alveolar wall apoptosis causes lung destruction and emphysematous changes.

Authors:  Kazutetsu Aoshiba; Naoko Yokohori; Atsushi Nagai
Journal:  Am J Respir Cell Mol Biol       Date:  2003-05       Impact factor: 6.914

6.  The mechanism of cytokeratin aggresome formation: the role of mutant ubiquitin (UBB+1).

Authors:  F Bardag-Gorce; N Riley; V Nguyen; R O Montgomery; B A French; J Li; F W van Leeuwen; W Lungo; L W McPhaul; S W French
Journal:  Exp Mol Pathol       Date:  2003-04       Impact factor: 3.362

7.  Imaging and tracking of tat peptide-conjugated quantum dots in living cells: new insights into nanoparticle uptake, intracellular transport, and vesicle shedding.

Authors:  Gang Ruan; Amit Agrawal; Adam I Marcus; Shuming Nie
Journal:  J Am Chem Soc       Date:  2007-11-06       Impact factor: 15.419

8.  Nanoparticles functionalized with Pep-1 as potential glioma targeting delivery system via interleukin 13 receptor α2-mediated endocytosis.

Authors:  Baoyan Wang; Lingyan Lv; Zhongyuan Wang; Yue Zhao; Lin Wu; Xiaoling Fang; Qunwei Xu; Hongliang Xin
Journal:  Biomaterials       Date:  2014-04-16       Impact factor: 12.479

9.  Cationic antimicrobial peptides : issues for potential clinical use.

Authors:  Jeremy Bradshaw
Journal:  BioDrugs       Date:  2003       Impact factor: 5.807

10.  Influence of short-chain cell-penetrating peptides on transport of doxorubicin encapsulating receptor-targeted liposomes across brain endothelial barrier.

Authors:  Gitanjali Sharma; Amit Modgil; Tiecheng Zhong; Chengwen Sun; Jagdish Singh
Journal:  Pharm Res       Date:  2013-11-16       Impact factor: 4.200

View more
  2 in total

1.  Delivery of a Protease-Activated Cytolytic Peptide Prodrug by Perfluorocarbon Nanoparticles.

Authors:  Andrew P Jallouk; Rohun U Palekar; Jon N Marsh; Hua Pan; Christine T N Pham; Paul H Schlesinger; Samuel A Wickline
Journal:  Bioconjug Chem       Date:  2015-07-02       Impact factor: 4.774

Review 2.  Peptide-Based Nanoparticles for Therapeutic Nucleic Acid Delivery.

Authors:  Prisca Boisguérin; Karidia Konate; Emilie Josse; Eric Vivès; Sébastien Deshayes
Journal:  Biomedicines       Date:  2021-05-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.